FDA Approves Wegovy (Semaglutide) for Obesity in Teens 12 and Up ...Middle East

News by : (Medscape) -
FDA approves semaglutide 2.4mg (Wegovy), a once-weekly subcutaneous injection, for treating obesity in adolescents aged 12 years and older. Medscape Medical News

Hence then, the article about fda approves wegovy semaglutide for obesity in teens 12 and up was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Wegovy (Semaglutide) for Obesity in Teens 12 and Up )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار